DRAP services

14/08/2026

On this 14th August, Pharma Point Advisors proudly celebrates the spirit of freedom, unity, resilience, and progress.

As a regulatory consultancy serving the healthcare and pharmaceutical sector, we remain committed to contributing to a healthier, stronger, and more progressive Pakistan through integrity, professionalism, and dedicated service.

Let’s continue working together for a brighter future. 💚

Pakistan Zindabad! 🇵🇰

13/08/2026

The Drug Regulatory Authority of Pakistan (DRAP) has shared a video tutorial regarding the updating of existing product data on the eApp system, with reference to O.M. No. 28/2026-Dir(MIS), dated 6 August 2026.
This update is important for manufacturers, importers, and regulatory professionals who need to ensure that their existing product information is correctly updated in the eApp system.
🎥 Video Tutorial & Official DRAP Update:
DRAP – Video Tutorial for Updation of Existing Product Data on eApp

https://lnkd.in/d_rWYZFb

This link will take you to a page that’s not on LinkedIn

11/08/2026

DRAP Interaction Sessions at Pak Pharma & Health Expo 2026
The Drug Regulatory Authority of Pakistan (DRAP) will hold dedicated interaction sessions during the Pak Pharma & Health Expo / Pharma Innovation Summit 2026 on 13 August 2026.
The sessions will focus on key regulatory matters, including:
🔹 Pharmacovigilance obligations of pharmaceutical manufacturers
🔹 Registration applications – common deficiencies and regulatory expectations
🔹 Alternative Medicines & Health Products Rules, 2026 – regulatory framework and industry readiness
DRAP has invited industry associations and stakeholders to actively participate, share concerns, and seek clarification on regulatory issues through structured discussions.
These sessions provide an important opportunity for the pharmaceutical and healthcare industry to engage directly with DRAP and contribute to improved regulatory clarity, compliance, and effective implementation of regulatory requirements.
Pharma Point Advisors looks forward to following these important regulatory developments and sharing key updates with the industry.

22/07/2026

📢 DRAP has released the decisions of the 128th, 129th, 131st, 133rd & 134th
Medical Device Board (MDB) meetings. These publications provide valuable regulatory insights for medical device manufacturers, importers, and authorized representatives regarding product registrations, documentation requirements, and board decisions.

Staying updated with MDB decisions can help applicants better understand DRAP's expectations and prepare stronger, compliant submissions.
📄 Official Publication: DRAP MDB Meeting Decisions
📄 Official DRAP Publication:https://lnkd.in/eEuHPPdJ

26/06/2026

DRAP REGISTRATION EXPERTS
Medical Devices | Nutraceuticals
Complete Regulatory Solutions

✅ Product Registration
✅ Dossier Preparation
✅ Application Submission
✅ Query & Deficiency Handling
✅ Scientific Justifications
✅ Follow-up Until Approval

Why Pharma Point?

✔ 10+ Years of Regulatory Experience
✔ Qualified Pharmacists
✔ Expert in DRAP Compliance
✔ End-to-End Regulatory Support

Get Your Product Registered with Confidence

📞 0311-7306089
📧 [email protected]
www.pharmapointadvisor.com

PHARMA POINT ADVISORS

One Solution for All Your Regulatory Problems.

DRAP services Drug Regulatory Authority of Pakistan (DRAP) Medical equipment and medical devices supplier Online Business Registration Service Medical Devices

15/06/2026

🚨 Important Update for Pakistan's Pharmaceutical Industry

The Drug Regulatory Authority of Pakistan (DRAP) is conducting a Technical Session on Online Track & Trace System Implementation to discuss the rollout and implementation of the national track & trace framework.

📅 Date: 29 June 2026
🕚 Time: 11:00 AM
📍 Platform: DRAP Facebook Live

This session will provide valuable insights for pharmaceutical manufacturers, importers, distributors, regulatory professionals, and other stakeholders regarding compliance requirements and implementation procedures.

Stay informed and participate to better understand the future of pharmaceutical traceability and regulatory compliance in Pakistan.

17/05/2026

Pakistan’s medical device industry is growing rapidly — creating major opportunities for importers, distributors, and local manufacturers.

With increasing demand in hospitals, diagnostics, clinics, and home healthcare, the market is expected to grow significantly in the coming years. Since 90%+ medical devices are still imported, strong opportunities exist for businesses entering this sector professionally.

In this carousel, we highlight:
✔ Market growth potential
✔ Import dependency opportunities
✔ High-demand product categories
✔ Common regulatory challenges
✔ How Pharma Point Advisors can help

Proper DRAP regulatory planning is essential for successful market entry and long-term growth.

📩 Planning to import or register medical devices in Pakistan? Connect with Pharma Point Advisors.

26/04/2026

Looking to launch your own Herbal or Nutraceutical Brand without the hassle of manufacturing?

We’ve got you covered! 🌿💊

At Pharma Point Advisors, we offer Toll / Third-Party Manufacturing Services for:

✔ Herbal Products
✔ Nutraceutical Supplements
✔ Capsules, Tablets, Syrups & Powders
✔ Custom Formulations & Private Labeling

💼 Why choose us?
✔ DRAP-compliant solutions
✔ End-to-end support (Formulation → Manufacturing → Documentation)
✔ High-quality production standards
✔ Fast & reliable service

🚀 Start your brand with confidence — we handle everything for you!

📞 Contact Now: 03117306089

31/03/2026

DRAP Notification: Schedule announced for the 356th to 359th Registration Board meetings, covering meeting dates, case categories, and attendance details.

19/03/2026

Important Update from Drug Regulatory Authority of Pakistan (DRAP)
The Government of Pakistan has issued a “Most Immediate / Most Urgent” directive to accelerate the processing of therapeutic goods and import consignments.
📌 Key Highlights:
✔️ Registration/enlistment letters to be issued within 5 working days after approval
✔️ Evaluation of imported medicine applications to be completed within 10 working days
✔️ API-related applications to be processed within 5–7 working days
✔️ Pending cases under Rule 26(2) of Medical Devices Rules 2017 to be resolved within 3 working days
✔️ Virtual inspections for medical device manufacturers introduced for 6 months to fast-track registrations
✔️ Pre-Import Clearance Certificate processing time reduced from 72 hours to 48 hours via PSW/OIES
📊 This initiative reflects a strong commitment towards efficiency, transparency, and ease of doing business in Pakistan’s healthcare and regulatory sector.
💡 A positive step for pharmaceutical and medical device companies aiming for faster market access.